N/A
Completed N=1,849
Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada
Source: ClinicalTrials.gov NCT01683630 ↗Enrolled (actual)
1,849
Serious AEs
—
Results posted
Oct 2015
Primary outcomePrimary: Age Adjusted Percentage of Participants With a Physician Visit Due to Any Diagnosis Within 30 Days of the Index Date of the Confirmed Influenza A and B Cases in the Province of Manitoba — 23.5; 22.1 Percentage of participants
Summary
This study compares the epidemiology and clinical outcomes of laboratory confirmed influenza type A to type B following clinical diagnosis of influenza. Multivariate models are used to assess the effects of influenza type on clinical outcomes while accounting for potential confounders.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Age Adjusted Percentage of Participants With a Physician Visit Due to Any Diagnosis Within 30 Days of the Index Date of the Confirmed Influenza A and B Cases in the Province of Manitoba |
23.5; 22.1 | — |
| PRIMARY Percentage of Participants With a Risk of Hospitalization Due to Any Diagnosis Within 30 Days Following the Index Date of Confirmed Cases of Influenza A and B in the Province of Manitoba |
9.0; 7.0 | — |
| PRIMARY Risk of Death Due to Any Cause During 30 Days Following the Index Date of Laboratory Confirmed Cases of Influenza A and B in the Province of Manitoba |
4.5; 2.0 | — |
Eligibility Criteria
Inclusion Criteria
- Any person who normally resides in Manitoba and who has been continuously covered by Manitoba Health during the study period will be eligible for inclusion in the study.
Exclusion Criteria
Data sourced from ClinicalTrials.gov (NCT01683630). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.